intravitreal injectionsIntravitreal therapiesmacular diseasesBevacizumabafliberceptfluocinoloneranibizumabDexamethasonebrolucizumabfaricimab
…ends (p<0.05).Results A total of 3,223 patients received 31,826 intravitreal injections. Bevacizumab was the most frequently prescribed drug (58.73%, n…